Sickle-Cell Treatment Created With Gene Editing Wins U.K. ApprovalSickle-Cell Treatment Created With Gene Editing Wins U.K. Approval
Regulators in Britain on Thursday approved the first treatment derived from CRISPR, the revolutionary gene-editing method. Called Casgevy, the treatment is intended to cure sickle-cell disease and a related condition,